Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$11.93
+0.5%
$11.63
$9.30
$25.36
$553.74M1.12541,221 shs647,282 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$21.36
-0.4%
$21.11
$16.59
$33.14
$535.50M1.12196,722 shs89,596 shs
Profound Medical stock logo
PROF
Profound Medical
$4.47
-1.3%
$5.55
$3.89
$9.35
$134.34M0.5278,463 shs37,275 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$18.88
-0.1%
$14.81
$8.15
$19.00
$532.42M2.2288,828 shs300,975 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-0.03%+6.67%+0.66%-5.50%-50.66%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-0.88%+11.96%-3.73%+6.30%-32.22%
Profound Medical stock logo
PROF
Profound Medical
+0.22%-1.52%-17.03%-13.38%-49.78%
ZimVie Inc. stock logo
ZIMV
ZimVie
-0.37%-0.16%+0.48%+106.33%+10.59%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
3.4092 of 5 stars
0.03.00.00.03.83.32.5
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
4.4115 of 5 stars
3.41.00.03.93.05.00.6
Profound Medical stock logo
PROF
Profound Medical
1.8105 of 5 stars
3.51.00.00.02.30.80.6
ZimVie Inc. stock logo
ZIMV
ZimVie
0.6658 of 5 stars
1.03.00.00.02.91.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2.00
HoldN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
2.88
Moderate Buy$34.1459.84% Upside
Profound Medical stock logo
PROF
Profound Medical
3.00
Buy$11.00146.09% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.00
Hold$17.75-5.99% Downside

Current Analyst Ratings Breakdown

Latest PROF, AVNS, ZIMV, and KIDS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2025
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
Zacks Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
8/8/2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetMarket Outperform ➝ Market Outperform$50.00 ➝ $35.00
8/8/2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform
8/6/2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$40.00 ➝ $39.00
7/31/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$19.00
7/22/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Equal Weight$9.00 ➝ $19.00
7/14/2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
(Data available from 8/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$687.80M0.81$11.93 per share1.00$16.73 per share0.71
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$204.73M2.62N/AN/A$14.18 per share1.51
Profound Medical stock logo
PROF
Profound Medical
$11.84M11.35N/AN/A$1.31 per share3.41
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M1.18$1.85 per share10.21$14.64 per share1.29
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-$392.10M-$10.07N/A6.90N/A-66.89%6.16%4.57%10/29/2025 (Estimated)
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$37.82M-$1.79N/AN/AN/A-18.92%-6.36%-4.69%11/5/2025 (Estimated)
Profound Medical stock logo
PROF
Profound Medical
-$27.82M-$1.46N/AN/AN/A-343.97%-89.74%-73.06%11/6/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.70N/AN/A-4.39%6.37%3.34%10/29/2025 (Estimated)

Latest PROF, AVNS, ZIMV, and KIDS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Profound Medical stock logo
PROF
Profound Medical
-$0.43-$0.52-$0.09-$0.52$4.75 million$2.21 million
8/5/2025Q2 2025
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$0.18$0.17-$0.01-$1.66$165.50 million$175.00 million
8/5/2025Q2 2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.17-$0.11+$0.06-$0.30$61.40 million$61.08 million
7/30/2025Q2 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.2080$0.26+$0.0520-$0.14$112.60 million$116.66 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
N/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
N/AN/AN/AN/AN/A
Profound Medical stock logo
PROF
Profound Medical
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
0.12
2.64
1.58
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.27
6.66
3.43
Profound Medical stock logo
PROF
Profound Medical
0.11
8.53
7.07
ZimVie Inc. stock logo
ZIMV
ZimVie
0.56
2.37
1.60

Institutional Ownership

CompanyInstitutional Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
95.17%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
69.05%
Profound Medical stock logo
PROF
Profound Medical
47.86%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2.64%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
32.70%
Profound Medical stock logo
PROF
Profound Medical
1.52%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2,22746.40 million45.18 millionOptionable
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
20025.07 million16.88 millionOptionable
Profound Medical stock logo
PROF
Profound Medical
15030.05 million29.60 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77028.20 million27.35 millionOptionable

Recent News About These Companies

ZimVie Reports Second Quarter 2025 Financial Results
Insights into ZimVie's Upcoming Earnings
ZimVie to sell to investment firm for about $730M

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Avanos Medical stock logo

Avanos Medical NYSE:AVNS

$11.93 +0.06 (+0.54%)
Closing price 03:59 PM Eastern
Extended Trading
$11.92 -0.01 (-0.08%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

OrthoPediatrics stock logo

OrthoPediatrics NASDAQ:KIDS

$21.36 -0.08 (-0.37%)
Closing price 04:00 PM Eastern
Extended Trading
$21.36 0.00 (0.00%)
As of 05:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Profound Medical stock logo

Profound Medical NASDAQ:PROF

$4.47 -0.06 (-1.32%)
Closing price 03:59 PM Eastern
Extended Trading
$4.47 +0.00 (+0.11%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$18.88 -0.02 (-0.11%)
Closing price 04:00 PM Eastern
Extended Trading
$18.82 -0.06 (-0.30%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.